Restoration of Cytoskeleton Homeostasis After Gigaxonin Gene Transfer for Giant Axonal Neuropathy-Reference-Cited by-同舟云学术

Restoration of Cytoskeleton Homeostasis After Gigaxonin Gene Transfer for Giant Axonal Neuropathy

Published:2013-02 Issue:2 Volume:24 Page:209-219
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Mussche Silke¹,Devreese Bart²,Nagabhushan Kalburgi Sahana³,Bachaboina Lavanya³,Fox Jonathan C.³,Shih Hung-Jui³,Van Coster Rudy¹,Samulski R. Jude³,Gray Steven J.³

Affiliation:

1. Department of Pediatrics, Division of Pediatric Neurology and Metabolism, Ghent University Hospital, Ghent 9000, Belgium.

2. Laboratory for Protein Biochemistry and Biomolecular Engineering, Ghent University, Ghent 9000, Belgium.

3. Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2012.107

Reference37 articles.

1. Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival

2. GIANT AXONAL NEUROPATHY

3. Intermediate filament aggregation in fibroblasts of giant axonal neuropathy patients is aggravated in non dividing cells and by microtubule destabilization

4. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy

5. Identification of seven novel mutations in theGAN gene

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AAV gene replacement therapy for treating MPS IIIC: Facilitating bystander effects via EV‐mRNA cargo;Journal of Extracellular Vesicles;2024-07

2. Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials;Neurotherapeutics;2024-07

3. Functional Characterization of a Spectrum of Genetic Variants in a Family with Succinic Semialdehyde Dehydrogenase Deficiency;International Journal of Molecular Sciences;2024-05-11

4. Intrathecal gene therapy for neurologic disease in humans;Molecular Therapy;2024-05

5. Intrathecal Gene Therapy for Giant Axonal Neuropathy;New England Journal of Medicine;2024-03-21